Secondary Logo

Journal Logo

March 1st, 2000 - Volume 23 - Issue 3
pp: 209-286,A8-A36

PDF Only



PDF Only


Rapid Communication: Efavirenz- and Adefovir Dipivoxil-Based Salvage Therapy in Highly Treatment-Experienced Patients: Clinical and Genotypic Predictors of Virologic Response

Shulman, Nancy S.; Zolopa, Andrew R.; Passaro, Douglas J.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):221-226, March 1st, 2000.

Phase II Placebo-Controlled Trial of Fozivudine Tidoxil for HIV Infection: Pharmacokinetics, Tolerability, and Efficacy

Girard, Pierre-Marie; Pegram, Paul Samuel; Diquet, Bertrand; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):227-235, March 1st, 2000.

Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study

Bonfanti, Paolo; Valsecchi, Laura; Parazzini, Fabio; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):236-245, March 1st, 2000.


PDF Only


Randomized Trial of Vitamin Supplements in Relation to Vertical Transmission of HIV-1 in Tanzania

Fawzi, Wafaie W.; Msamanga, Gernard; Hunter, David; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):246-254, March 1st, 2000.

Dual Nucleoside Regimens in Nonadvanced HIV Infection: Prospective Follow-Up of 130 Patients, Aquitaine Cohort, 1996 to 1998

Morlat, P.; Marimoutou, C.; Dequae-Merchadou, L.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):255-260, March 1st, 2000.

Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998

Thiébaut, R.; Dabis, F.; Malvy, D.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):261-265, March 1st, 2000.

Correlates of Risky Behaviors Among Young and Older Men Having Sexual Relations With Men in Montréal, Québec, Canada

Dufour, Annie; Alary, Michel; Otis, Joanne; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):272-278, March 1st, 2000.


PDF Only



PDF Only


TREATMENT OF AIDS LYMPHOMA WITH HIGH-DOSE CHEMOTHERAPY AND GENETICALLY MODIFIED STEM CELLS: A MODEL FOR EVALUATION OF GENE THERAPY.: ABSTRACT S19

Zaia, J.; Krishnan, A.; Rossi, J. J.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):A12, March 1st, 2000.

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS ACTIVE AS ANTI-KAPOSI'S SARCOMA (KS) THERAPY: RESULTS OF A TRIAL IN 53 PATIENTS (PTS): ABSTRACT 30

Vaccher, E; Maserati, R; Mongiovetti, M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3):A22, March 1st, 2000.

Show: